UY27589A1 - Metodos y composiciones para el tratamiento de patologías respiratorias - Google Patents

Metodos y composiciones para el tratamiento de patologías respiratorias

Info

Publication number
UY27589A1
UY27589A1 UY27589A UY27589A UY27589A1 UY 27589 A1 UY27589 A1 UY 27589A1 UY 27589 A UY27589 A UY 27589A UY 27589 A UY27589 A UY 27589A UY 27589 A1 UY27589 A1 UY 27589A1
Authority
UY
Uruguay
Prior art keywords
compositions
methods
treatment
pathologies
respiratory pathologies
Prior art date
Application number
UY27589A
Other languages
English (en)
Inventor
Bueno Lionel
Original Assignee
Rytex
Rytek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0116706A external-priority patent/FR2833839A1/fr
Application filed by Rytex, Rytek filed Critical Rytex
Publication of UY27589A1 publication Critical patent/UY27589A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente solicitud se refiere a composiciones y métodos para tratar patologías respiratorias. También se refiere a composiciones y métodos que permiten la regulación de la permeabilidad paracelular del epitelio pulmonar, Las composiciones y los métodos de la invención se basan. en particular, en el uso de agentes o condiciones que modulan la tensión del citoesqueleto de las células epiteliales pulmonares, en particular, los enterocitos. La invención puede usarse para el tratamiento preventivo o curativo de varias patologías, como el asma las alergias, las enfermedades obstructivas, etc. en mamíferos, particularmente en seres humanos.
UY27589A 2001-12-21 2002-12-18 Metodos y composiciones para el tratamiento de patologías respiratorias UY27589A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116706A FR2833839A1 (fr) 2001-12-21 2001-12-21 Methodes et compositions pour le traitement de pathologies respiratoires
FR0208606A FR2833840B1 (fr) 2001-12-21 2002-07-09 Methodes et compositions pour le traitement de pathologies respiratoires

Publications (1)

Publication Number Publication Date
UY27589A1 true UY27589A1 (es) 2003-05-30

Family

ID=26213306

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27589A UY27589A1 (es) 2001-12-21 2002-12-18 Metodos y composiciones para el tratamiento de patologías respiratorias

Country Status (12)

Country Link
US (2) US20030125321A1 (es)
EP (1) EP1455767A2 (es)
AR (1) AR038042A1 (es)
AU (1) AU2002364679A1 (es)
CA (1) CA2470442A1 (es)
FR (1) FR2833840B1 (es)
PA (1) PA8562701A1 (es)
PE (1) PE20030853A1 (es)
SV (1) SV2003001439A (es)
TW (1) TW200305447A (es)
UY (1) UY27589A1 (es)
WO (1) WO2003053422A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20050129679A1 (en) * 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
TWI357414B (en) * 2003-12-17 2012-02-01 Wyeth Llc Aβ immunogenic peptide carrier conjugates and meth
WO2006023844A2 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
FR2879100B1 (fr) * 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
EP2111863B1 (en) 2005-10-26 2012-03-28 Asahi Kasei Pharma Corporation Fasudil in combination with bosentan for the treament of pulmonary arterial hypertension
EP2091551B1 (en) * 2006-11-03 2020-01-15 Alba Therapeutics Corporation Method of treating asthma
US20150038674A1 (en) * 2013-08-05 2015-02-05 Bayrak Bertan Boran Use of glp-2 analogues in pulmonary diseases for therapeutic purpose

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3748A (en) * 1844-09-17 Improvement in ratoon and cane cutters
US5030631A (en) * 1989-11-27 1991-07-09 Schering Corporation Tricylclic arylsulfonamides
FR2674434B1 (fr) * 1991-03-27 1993-06-18 Nativelle Sa Ets Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
US5336503A (en) * 1992-03-31 1994-08-09 Daiichi Pharmaceutical Co., Ltd. Anti-peptic ulcer agent
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
KR950701329A (ko) * 1993-02-19 1995-03-23 유미꾸라 레이이찌 벤조티아졸술폰아미드 유도체, 그의 제조법 및 그 용도(Benzothiazolesulfornamide derivative, method for preparing the same, and use thereof)
AU703540B2 (en) * 1996-03-26 1999-03-25 Meddiss, Incorporated Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
CZ301044B6 (cs) * 1996-08-12 2009-10-21 Mitsubishi Tanabe Pharma Léciva obsahující amidové deriváty inhibující Rho kinázu
EP1015492A2 (en) * 1997-09-19 2000-07-05 Magainin Pharmaceuticals Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
AU4990599A (en) * 1998-07-14 2000-02-07 Brigham And Women's Hospital Upregulation of type iii endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization
DE60128701T2 (de) * 2000-08-15 2008-02-07 Immunex Corp., Thousand Oaks Claudin polypeptide

Also Published As

Publication number Publication date
AU2002364679A1 (en) 2003-07-09
TW200305447A (en) 2003-11-01
WO2003053422A2 (fr) 2003-07-03
FR2833840B1 (fr) 2010-06-18
WO2003053422A3 (fr) 2004-04-15
FR2833840A1 (fr) 2003-06-27
US20050019314A1 (en) 2005-01-27
PA8562701A1 (es) 2004-02-16
SV2003001439A (es) 2003-11-04
PE20030853A1 (es) 2003-10-28
AU2002364679A8 (en) 2003-07-09
EP1455767A2 (fr) 2004-09-15
US20030125321A1 (en) 2003-07-03
AR038042A1 (es) 2004-12-22
CA2470442A1 (fr) 2003-07-03

Similar Documents

Publication Publication Date Title
BR112014033102A2 (pt) produto para uso no tratamento profilático ou terapêutico de uma emoção negativa ou comportamento introvertido
MX2011013060A (es) Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
ECSP088283A (es) Compuestos de piridina 5- (fenilisoxazoliletoxi) -triazol- 3-ilo substituidos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
AR034660A1 (es) Nebulizador para la aplicacion de liquidos sobre la cornea del ojo
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
MX2009009207A (es) Metodos y composiciones para normalizar las secreciones de glandulas meibomianas.
BRPI0512864A (pt) composições e métodos para o tratamento de condições e desordens oculares
AR113422A2 (es) Agentes tensioactivos reconstituidos que tienen propiedades mejoradas
EA200802364A1 (ru) Композиция для ухода за кожей и ее применение
CY1110980T1 (el) Εμβολιο συνδυασμων πεπτιδιων εναντια στην αλλεργια απο γατες
SV2008003032A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
AR034023A1 (es) Compuestos benzimidazoles para modular la ige e inhibir la proliferacion celular
BRPI0803568B8 (pt) composição mucoaderente
DOP2001000233A (es) Compuestos farmacéuticos
WO2007143557A3 (en) Compounds and methods for treating mammalian gastrointestinal parasitic infections
ATE489948T1 (de) Behandlung von autoimmunkrankheiten
UY27589A1 (es) Metodos y composiciones para el tratamiento de patologías respiratorias
BR0117009A (pt) Composiçoes para utilização no tratamento de distúrbios associados a ige
UY29417A1 (es) Agentes endoparasiticidas
CR9012A (es) Compuestos de 4-amino-sustituido-2-sustituido-1,2,3,4-tetrahidroquinolina
CY1118967T1 (el) Φαρμακευτικες συνθεσεις υψηλης δοσης βιοτινης
ATE446098T1 (de) Verwendung von polyethylenglycol bei entzündungsbedingten topischen erkrankungen oder erkrankungen und wundheilung
MX2009008548A (es) Formulaciones de olopatadina para administracion nasal topica.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150126